MASTER INVESTOR SHOW 2020
The UK's largest event for private investors
Business Design Centre, London, 28 March 2020
AgeX Theurapeutics, Inc.
AgeX Therapeutics, Inc. (Alameda, CA) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem® and UniverCyte™manufacturing and immunotolerance technologies work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a whole host of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeX’s revolutionary longevity platform named induced Tissue Regeneration (iTR™) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues.
Ticker: NYSE American: AGE
Get your ticket
Don't miss out on the UK's largest event for private investors - secure your ticket today.
Book your stand
Join us as exhibitor and get maximum exposure to around 5,000 private investors. Increase liquidity in your company's shares, generate new leads and build your brand name in the minds of the right audience.
Check out our dedicated 'Investor Access’ microsite for more information or get in touch for a no obligation consultation.